Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
6896 Stock Overview
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China.
Golden Throat Holdings Group Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$1.80 |
52 Week High | HK$2.74 |
52 Week Low | HK$1.35 |
Beta | -0.54 |
1 Month Change | -15.09% |
3 Month Change | -1.10% |
1 Year Change | -19.28% |
3 Year Change | -7.22% |
5 Year Change | -28.85% |
Change since IPO | -63.04% |
Recent News & Updates
Estimating The Intrinsic Value Of Golden Throat Holdings Group Company Limited (HKG:6896)
Does the May share price for Golden Throat Holdings Group Company Limited ( HKG:6896 ) reflect what it's really worth...
Shareholder Returns
6896 | HK Personal Products | HK Market | |
---|---|---|---|
7D | -4.8% | 3.2% | 1.5% |
1Y | -19.3% | -12.9% | -22.7% |
Return vs Industry: 6896 underperformed the Hong Kong Personal Products industry which returned -12.9% over the past year.
Return vs Market: 6896 exceeded the Hong Kong Market which returned -22.7% over the past year.
Price Volatility
6896 volatility | |
---|---|
6896 Average Weekly Movement | 6.0% |
Personal Products Industry Average Movement | 7.5% |
Market Average Movement | 6.6% |
10% most volatile stocks in HK Market | 12.8% |
10% least volatile stocks in HK Market | 3.2% |
Stable Share Price: 6896 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 6896's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1956 | 937 | Yong Zeng | https://www.goldenthroat.com |
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats.
Golden Throat Holdings Group Fundamentals Summary
6896 fundamental statistics | |
---|---|
Market Cap | CN¥1.14b |
Earnings (TTM) | CN¥187.64m |
Revenue (TTM) | CN¥820.54m |
6.1x
P/E Ratio1.4x
P/S RatioIs 6896 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6896 income statement (TTM) | |
---|---|
Revenue | CN¥820.54m |
Cost of Revenue | CN¥242.81m |
Gross Profit | CN¥577.74m |
Other Expenses | CN¥390.09m |
Earnings | CN¥187.64m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0.25 |
Gross Margin | 70.41% |
Net Profit Margin | 22.87% |
Debt/Equity Ratio | 17.2% |
How did 6896 perform over the long term?
See historical performance and comparisonDividends
9.6%
Current Dividend Yield58%
Payout RatioValuation
Is 6896 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6896?
Other financial metrics that can be useful for relative valuation.
What is 6896's n/a Ratio? | |
---|---|
n/a Ratio | 0x |
n/a | n/a |
Market Cap | CN¥1.14b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.7x |
Enterprise Value/EBITDA | 2.2x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 6896's PE Ratio compare to its peers?
6896 PE Ratio vs Peers |
---|
Company | PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 17.3x | ||
1962 Evergreen Products Group | 10.5x | n/a | HK$569.4m |
1455 Fourace Industries Group Holdings | 4.5x | n/a | HK$265.9m |
8281 China Golden Classic Group | 14.5x | n/a | HK$198.0m |
8436 Takbo Group Holdings | 39.7x | n/a | HK$70.0m |
6896 Golden Throat Holdings Group | 6.1x | n/a | HK$1.3b |
Price-To-Earnings vs Peers: 6896 is good value based on its Price-To-Earnings Ratio (6.1x) compared to the peer average (17.3x).
Price to Earnings Ratio vs Industry
How does 6896's PE Ratio compare vs other companies in the Asian Personal Products Industry?
Price-To-Earnings vs Industry: 6896 is good value based on its Price-To-Earnings Ratio (6.1x) compared to the Hong Kong Personal Products industry average (11.5x)
Price to Earnings Ratio vs Fair Ratio
What is 6896's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 6.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6896's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 6896 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 6896 (HK$1.8) is trading above our estimate of fair value (HK$1.2)
Significantly Below Fair Value: 6896 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Future Growth
How is Golden Throat Holdings Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
15.6%
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Golden Throat Holdings Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine Golden Throat Holdings Group's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Golden Throat Holdings Group competitive advantages and company strategy can generally be found in its financial reports archived here.
Past Performance
How has Golden Throat Holdings Group performed over the past 5 years?
Past Performance Score
3/6Past Performance Score 3/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
26.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6896 has high quality earnings.
Growing Profit Margin: 6896's current net profit margins (22.9%) are lower than last year (23.8%).
Past Earnings Growth Analysis
Earnings Trend: 6896's earnings have grown significantly by 26.3% per year over the past 5 years.
Accelerating Growth: 6896's earnings growth over the past year (21.8%) is below its 5-year average (26.3% per year).
Earnings vs Industry: 6896 earnings growth over the past year (21.8%) exceeded the Personal Products industry -13%.
Return on Equity
High ROE: 6896's Return on Equity (13.7%) is considered low.
Discover strong past performing companies
Financial Health
How is Golden Throat Holdings Group's financial position?
Financial Health Score
5/6Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: 6896's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥579.2M).
Long Term Liabilities: 6896's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥8.8M).
Debt to Equity History and Analysis
Debt Level: 6896 has more cash than its total debt.
Reducing Debt: 6896's debt to equity ratio has increased from 6.7% to 17.2% over the past 5 years.
Debt Coverage: 6896's debt is well covered by operating cash flow (70.3%).
Interest Coverage: 6896 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Dividend
What is Golden Throat Holdings Group current dividend yield, its reliability and sustainability?
Dividend Score
3/6Dividend Score 3/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
9.56%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 6896's dividend (9.56%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.82%).
High Dividend: 6896's dividend (9.56%) is in the top 25% of dividend payers in the Hong Kong market (8.35%)
Stability and Growth of Payments
Stable Dividend: 6896 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 6896's dividend payments have increased, but the company has only paid a dividend for 6 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (57.8%), 6896's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (94.1%), 6896's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
7.5yrs
Average board tenure
CEO
Yong Zeng (48 yo)
no data
Tenure
CN¥5,525,000
Compensation
Mr. Yong Zeng serves as Vice Chairman of the Board and General Manager at Golden Throat Holdings Group Company Limited. Mr. ZENG is primarily responsible for overseeing the management and strategic develop...
CEO Compensation Analysis
Compensation vs Market: Yong's total compensation ($USD818.19K) is above average for companies of similar size in the Hong Kong market ($USD303.06K).
Compensation vs Earnings: Yong's compensation has been consistent with company performance over the past year.
Board Members
Experienced Board: 6896's board of directors are considered experienced (7.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Golden Throat Holdings Group Company Limited's employee growth, exchange listings and data sources
Key Information
- Name: Golden Throat Holdings Group Company Limited
- Ticker: 6896
- Exchange: SEHK
- Founded: 1956
- Industry: Personal Products
- Sector: Household
- Implied Market Cap: HK$1.331b
- Shares outstanding: 739.30m
- Website: https://www.goldenthroat.com
Number of Employees
Location
- Golden Throat Holdings Group Company Limited
- No.28 Yuejin Road
- Liuzhou
- Guangxi Zhuang Province
- China
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/08/10 00:00 |
End of Day Share Price | 2022/08/10 00:00 |
Earnings | 2021/12/31 |
Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.